9 studies were found.

1.		Not yet recruiting	Atorvastatin Therapy in Patients with Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis Conditions: Multiple Sclerosis; Clinically Isolated Syndrome
2.		Recruiting	Combination Therapy to Prevent Kidney Transplant Rejection Condition: Kidney Transplantation
3.		Recruiting	Combined Bone Marrow and Kidney Transplant for Multiple Myeloma with Kidney Failure Conditions: Kidney Failure, Chronic; Multiple Myeloma
4.		Recruiting	Evaluation of a Diabetes Vaccine in Newly Diagnosed Diabetics Conditions: Insulin-Dependent Diabetes Mellitus; Diabetes Mellitus
5.		Recruiting	Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients with Relapsing Multiple Sclerosis (MS) Condition: Multiple Sclerosis
6.		No longer recruiting	Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies Conditions: Hay Fever; Hypersensitivity; Allergy; Rhinitis
7.		Recruiting	Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant Conditions: Kidney Failure; Bone Marrow Transplantation; Kidney Transplantation; Kidney Failure, Chronic
8.		No longer recruiting	Safety of RG2077 in Patients With Multiple Sclerosis Conditions: Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting
9.		Recruiting	Treating Systemic Lupus Erythematosus (SLE) Patients with CTLA4-IgG4m (RG2077) Conditions: Lupus Erythematosus, Systemic; Lupus Nephritis